Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients

Clinical trial NCT04072887 · COMPLETED

Trial details

NCT number: NCT04072887
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2019-09-12
Primary completion: 2021-10-08
Enrollment: 974

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.